Articles: PubMed: [Homologs of 2-acetamino-4-nitropropoxybenzene (Falimint). 2. Metabolism of homologs]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 11. Plasma levels and urinary elimination in single and multiple administration]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropopoxybenzolum (Falimint). 10. Biotransformation of the active substance in chick embryo and in in vitro systems]. PubMed: [The pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzene (Falimint). Biotransformation of the agent in various animal species]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 8. Biotransformation of the active agents]. PubMed: [Use of Falimint in the preparation of children for fibrogastroduodenoscopy]. PubMed: [Pharmaceutic and biopharmaceutic assessment of acetylaminopropoxybenzolum (Falimint). 7. The buccal resorption of Falimint]. PubMed: [The pharmaceutical and biopharmaceutical assessment of acetylaminonitropropoxybenzene (Falimint). 6. Quantitative composition of metabolites]. PubMed: [Pharmaceutical and biopharmaceutical assessment of acetylaminopropoxybenzene (Falimint). 5. Characterization of metabolites of Falimint with square wave- and oscillopolarography]. PubMed: [Pharmaceutic and biopharmaceutic evaluation of acetylaminonitropropoxybenzene (Falimint). A Biotransformation of the active agent]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 3: Polarographic analysis and determination of active agents]. PubMed: [Use of falimint postoperatively in tonsillectomy]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzene (Falimint). 2. Purity studies with a multi-stage phase solubility analysis and evaluation]. PubMed: [Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzene (Falimint). 1. Studies on the purity of active substances].